Personalized Cancer Vaccines Global Market Report 2024

Description

Personalized cancer vaccines are treatments specifically designed to match an individual's unique tumor profile, with the goal of stimulating the immune system to target and eliminate cancer cells. These vaccines enhance the body's ability to recognize and combat specific cancer types, potentially improving treatment effectiveness and reducing the likelihood of recurrence.

The main categories of personalized cancer vaccines include preventive cancer vaccines and therapeutic cancer vaccines. Preventive cancer vaccines aim to protect against infections or conditions that could lead to cancer. These vaccines can be utilized for various cancer types, including lung cancer, breast cancer, colorectal cancer, leukemia, prostate cancer, cervical cancer, and glioblastoma. They operate through different mechanisms of action, such as targeting tumor-associated antigens (TAAs), tumor-specific antigens (TSAs), and addressing somatic mutations in cancer pharmacogenomics, among other factors. They are administered via various routes, including injectables, and are used in a range of settings, such as hospitals and clinics.

The personalized cancer vaccines market research report is one of a series of new reports from The Business Research Company that provides personalized cancer vaccines market statistics, including personalized cancer vaccines industry global market size, regional shares, competitors with a personalized cancer vaccines market share, detailed personalized cancer vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cancer vaccines industry. This personalized cancer vaccines market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The personalized cancer vaccines market size has grown strongly in recent years. It will grow from $227.31 billion in 2023 to $242.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth observed during the historic period can be attributed to several factors, including advancements in genomic research, the development of targeted therapies, a deeper understanding of tumor immunology, progress in vaccine technology, and an increase in clinical trial data demonstrating efficacy.

The personalized cancer vaccines market size is expected to see strong growth in the next few years. It will grow to $315.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth during the forecast period can be attributed to several factors, including advancements in precision medicine, increased funding for cancer research, a rising prevalence of cancer cases, improvements in genetic sequencing technologies, and a growing interest in personalized treatment options. Key trends expected in this period include the integration of artificial intelligence in vaccine design, advancements in multi-antigen and neoantigen-based vaccines, a greater use of liquid biopsies for tumor monitoring, the expansion of combination therapies, and a heightened focus on personalized treatment regimens.

The rising incidence of cancer is projected to drive the growth of the personalized cancer vaccine market in the coming years. Cancer encompasses a range of diseases characterized by abnormal cell growth that can metastasize to other areas of the body. This increase in cancer prevalence is attributed to factors such as aging populations, changes in lifestyle, exposure to environmental pollutants, genetic predispositions, and advancements in diagnostic methods. Personalized cancer vaccines aim to combat this rising prevalence by specifically targeting tumor antigens that are unique to each patient, thereby enhancing the immune system's ability to identify and eliminate cancer cells. For example, a report from the Australian Institute of Health and Welfare in July 2024 indicated that cancer diagnoses in Australia rose from 160,570 cases in 2022 to 164,694 in 2023, showcasing a significant increase. Thus, the growing prevalence of cancer is propelling the expansion of the personalized cancer vaccine market.

Key players in the personalized cancer vaccine market are concentrating on developing innovative therapeutic options, such as personalized immunotherapy, to improve precision in addressing specific cancer mutations. These personalized immunotherapy solutions are tailored treatments that leverage a patient's unique genetic and tumor profiles to enhance immune responses against cancer. For instance, in August 2024, UCLA Health, a healthcare organization based in the U.S., initiated a groundbreaking clinical trial to assess the safety and efficacy of a cancer vaccine. This vaccine, developed at UCLA, employs a personalized immunotherapy approach to target the H3 G34 mutation associated with diffuse hemispheric gliomas, a highly aggressive brain tumor commonly found in adolescents and young adults. The method utilizes dendritic cells to activate the immune system specifically against the RNA disruptions caused by this mutation. This strategy, which has shown potential in treating other cancers, aims to improve outcomes for patients who often have limited treatment options and short survival rates.

In March 2022, NEC OncoImmunity AS, a biotechnology firm from Norway, acquired the neoantigen program assets from VAXIMM GmbH for an undisclosed sum. This acquisition is intended to bolster NEC OncoImmunity's development of neoantigen cancer vaccines, including patents and existing collaboration agreements. This strategic move will enhance NEC OncoImmunity's capacity to advance personalized cancer immunotherapies, building on their prior collaboration with VAXIMM. VAXIMM GmbH is a biopharmaceutical company based in Germany that specializes in the development of personalized cancer vaccines.

Major companies operating in the personalized cancer vaccines market are Merck & Co Inc, GlaxoSmithKline Plc, NEC Corporation, Moderna Inc, Catalent Inc, UCLA Health, Genetech Inc, NHS England, CureVac AG, Personalis Inc, Achilles Therapeutics Plc, Healio, Moffitt Corporation, BioPharma APAC, Celebrity Angels, EpiVax Therapeutics Inc., Evaxion Biotech AS, Geneos Therapeutics Inc, IFL Sciense, ISA Pharmaceuticals BV, Oxford Global, Kintara Therapeutics, VAXIMM Gmbh

North America was the largest region in the personalized cancer vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized cancer vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized cancer vaccines market consists of sales of patient-specific vaccines, neoantigen-based therapies, dendritic cell-based vaccines and peptide-based immunotherapies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Cancer Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized cancer vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized cancer vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized cancer vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Type: Preventive Cancer Vaccines; Therapeutic Cancer Vaccines
2) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Leukemia; Prostate Cancer; Cervical Cancer; Glioblastoma
3) By Mechanism Of Action: Tumor Associated Antigens (TAAs); Tumor Specific Antigens (TSAs); Somatic Mutations In Cancer Pharmacogenomics; Pharmacogenomics Towards Genomic Polymorphism; Other Mechanisms Of Action
4) By Route Of Administration: Injectables; Other Routes Of Administration
5) By End Use: Hospitals; Clinic; Other End Users
Companies Mentioned: Merck & Co Inc; GlaxoSmithKline Plc; NEC Corporation; Moderna Inc; Catalent Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20310

1. Executive Summary

2. Personalized Cancer Vaccines Market Characteristics

3. Personalized Cancer Vaccines Market Trends And Strategies

4. Personalized Cancer Vaccines Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Personalized Cancer Vaccines Market Size and Growth

5.1. Global Personalized Cancer Vaccines Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Personalized Cancer Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Personalized Cancer Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Personalized Cancer Vaccines Market Segmentation

6.1. Global Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
6.2. Global Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Prostate Cancer
Cervical Cancer
Glioblastoma
6.3. Global Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tumor Associated Antigens (TAAs)
Tumor Specific Antigens (TSAs)
Somatic Mutations In Cancer Pharmacogenomics
Pharmacogenomics Towards Genomic Polymorphism
Other Mechanisms Of Action
6.4. Global Personalized Cancer Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Injectables
Other Routes Of Administration
6.5. Global Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinic
Other End Users

7. Personalized Cancer Vaccines Market Regional And Country Analysis

7.1. Global Personalized Cancer Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Personalized Cancer Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Personalized Cancer Vaccines Market

8.1. Asia-Pacific Personalized Cancer Vaccines Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Personalized Cancer Vaccines Market

9.1. China Personalized Cancer Vaccines Market Overview
9.2. China Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Personalized Cancer Vaccines Market

10.1. India Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Personalized Cancer Vaccines Market

11.1. Japan Personalized Cancer Vaccines Market Overview
11.2. Japan Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Personalized Cancer Vaccines Market

12.1. Australia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Personalized Cancer Vaccines Market

13.1. Indonesia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Personalized Cancer Vaccines Market

14.1. South Korea Personalized Cancer Vaccines Market Overview
14.2. South Korea Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Personalized Cancer Vaccines Market

15.1. Western Europe Personalized Cancer Vaccines Market Overview
15.2. Western Europe Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Personalized Cancer Vaccines Market

16.1. UK Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Personalized Cancer Vaccines Market

17.1. Germany Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Personalized Cancer Vaccines Market

18.1. France Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Personalized Cancer Vaccines Market

19.1. Italy Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Personalized Cancer Vaccines Market

20.1. Spain Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Personalized Cancer Vaccines Market

21.1. Eastern Europe Personalized Cancer Vaccines Market Overview
21.2. Eastern Europe Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Personalized Cancer Vaccines Market

22.1. Russia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Personalized Cancer Vaccines Market

23.1. North America Personalized Cancer Vaccines Market Overview
23.2. North America Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Personalized Cancer Vaccines Market

24.1. USA Personalized Cancer Vaccines Market Overview
24.2. USA Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Personalized Cancer Vaccines Market

25.1. Canada Personalized Cancer Vaccines Market Overview
25.2. Canada Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Personalized Cancer Vaccines Market

26.1. South America Personalized Cancer Vaccines Market Overview
26.2. South America Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Personalized Cancer Vaccines Market

27.1. Brazil Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Personalized Cancer Vaccines Market

28.1. Middle East Personalized Cancer Vaccines Market Overview
28.2. Middle East Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Personalized Cancer Vaccines Market

29.1. Africa Personalized Cancer Vaccines Market Overview
29.2. Africa Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Personalized Cancer Vaccines Market Competitive Landscape And Company Profiles

30.1. Personalized Cancer Vaccines Market Competitive Landscape
30.2. Personalized Cancer Vaccines Market Company Profiles
- 30.2.1. Merck & Co Inc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. GlaxoSmithKline Plc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. NEC Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Moderna Inc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Catalent Inc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Personalized Cancer Vaccines Market Other Major And Innovative Companies

31.1. UCLA Health
31.2. Genetech Inc
31.3. NHS England
31.4. CureVac AG
31.5. Personalis Inc
31.6. Achilles Therapeutics Plc
31.7. Healio
31.8. Moffitt Corporation
31.9. BioPharma APAC
31.10. Celebrity Angels
31.11. EpiVax Therapeutics Inc.
31.12. Evaxion Biotech AS
31.13. Geneos Therapeutics Inc
31.14. IFL Sciense
31.15. ISA Pharmaceuticals BV

32. Global Personalized Cancer Vaccines Market Competitive Benchmarking

33. Global Personalized Cancer Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Personalized Cancer Vaccines Market

35. Personalized Cancer Vaccines Market Future Outlook and Potential Analysis

35.1 Personalized Cancer Vaccines Market In 2028 - Countries Offering Most New Opportunities
35.2 Personalized Cancer Vaccines Market In 2028 - Segments Offering Most New Opportunities
35.3 Personalized Cancer Vaccines Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer